Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
576 studies found for:    Open Studies | "Liver Neoplasms"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Liver Neoplasms"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting PET/CT-Assessment of Liver Tumor Ablation
Conditions: Liver Tumor;   Liver Neoplasms
Interventions: Radiation: N-13 ammonia;   Device: PET/CT scanner
2 Recruiting Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms
Conditions: Liver Neoplasms;   Hepatic Cancer;   Liver Cancer
Interventions: Procedure: Thermal Ablation;   Procedure: Standard External Beam Radiation Therapy
3 Recruiting Sorafenib and TRC105 in Hepatocellular Cancer
Conditions: Hepatoma;   Liver Neoplasms;   Adenoma, Liver Cell;   Carcinoma, Hepatocellular;   Liver Neoplasms, Experimental
Interventions: Drug: TRC 105;   Drug: Sorafenib
4 Recruiting Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer
Conditions: Hepatocellular Cancer;   Liver Cancer
Intervention: Drug: OMP-54F28 with Sorafenib
5 Not yet recruiting Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer
Conditions: Hepatocellular Cancer;   Liver Cancer
Interventions: Drug: Trametinib;   Drug: Sorafenib
6 Recruiting Follow-up Yttrium-90 Internal Pair Production PET/CT Imaging in Patients With Primary or Metastatic Liver Tumors as Compared With Brehmsstrahlung Imaging
Conditions: Liver Cancer;   Hepatic Tumors
Intervention: Device: PET/CT Scan
7 Unknown  Study of Hepatoma Treated by Perfusing Cinobufacin Through Hepatic Artery Combining Embolotherapy
Conditions: Hepatoma;   Cinobufacin Injection
Intervention: Drug: Cinobufacin injection
8 Unknown  Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor
Condition: Hepatocellular Cancer
Intervention: Drug: [Met5]-enkephalin (Infusion of opioid growth factor )
9 Unknown  Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors
Condition: Liver Tumors
Intervention: Radiation: Stereotactic Body Radiation Therapy
10 Recruiting Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)
Condition: Liver Cancer
Interventions: Procedure: Electrochemotherapy;   Device: Cliniporator Vitae®;   Drug: Bleomycin PHC 15 e. (United States Pharmacopeia - USP)
11 Recruiting Microwave Ablation of Resectable Liver Tumors
Conditions: Hepatocellular Carcinoma;   Liver Cancer
Intervention: Device: Microwave Ablation
12 Recruiting Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer
Condition: Liver Cancer
Intervention: Drug: Lipiodol
13 Recruiting TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer;   Liver Neoplasm;   Primary Liver Cancer
Intervention: Device: TheraSphere
14 Unknown  Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Condition: Liver Cancer
Interventions: Drug: doxorubicin-eluting beads;   Drug: sorafenib tosylate;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies;   Other: pharmacological study;   Procedure: quality-of-life assessment
15 Recruiting Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer
Condition: Hepatocellular Cancer
Interventions: Drug: Sorafenib;   Radiation: yttrium-90 radioembolization
16 Recruiting Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Conditions: Adult Primary Hepatocellular Carcinoma;   Adult Primary Undifferentiated Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Childhood Hepatocellular Carcinoma;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer;   Recurrent Childhood Liver Cancer;   Stage C Adult Primary Liver Cancer (BCLC);   Stage D Adult Primary Liver Cancer (BCLC);   Stage III Childhood Liver Cancer;   Stage IV Childhood Liver Cancer
Interventions: Drug: sorafenib tosylate;   Other: laboratory biomarker analysis
17 Recruiting 3-Tesla MRI Response to TACE in HCC (Liver Cancer)
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Resectable Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Stage A Adult Primary Liver Cancer (BCLC);   Stage B Adult Primary Liver Cancer (BCLC)
Interventions: Device: 3 Tesla Magnetic Resonance Imaging;   Drug: Magnevist® (Intravenous (IV) administration of MRI contrast agent)
18 Recruiting Tivozanib in Treating Patients With Liver Cancer That is Metastatic or Cannot Be Removed by Surgery
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer;   Stage C Adult Primary Liver Cancer (BCLC);   Stage D Adult Primary Liver Cancer (BCLC)
Interventions: Drug: tivozanib;   Other: pharmacological study;   Other: laboratory biomarker analysis
19 Recruiting Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma
Condition: Liver Cancer
Intervention: Radiation: Proton Beam Irradiation
20 Recruiting Ultrasound Guided Thoracic Paravertebral Block for Hepatic Tumors Ablation
Condition: Liver Cancer
Intervention: Drug: 0.5% marcaine 20ml

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years